Dr. Abu-Sayeef Mirza, MD, MPH

Dr. Mirza practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Mirza's NPI, 1811341977, was assigned on April 14, 2016. Dr. Mirza graduated from University of South Florida Morsani College of Medicine in 2016. Dr. Mirza holds Florida license ME133278.

Dr. Mirza's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Dr. Mirza's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Mirza to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mirza practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Mirza's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Mirza is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Mirza's licenses on file in 2 states: Florida and Connecticut.

CMS data shows 91 Medicare services from Dr. Mirza across 3 procedure codes in 2024, for 39 Medicare patients. Medicare paid $6,299 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 39 Medicare patients who saw Dr. Mirza in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mirza's median patient age at 64, with 41% women.

In 2024, Dr. Mirza wrote 192 Medicare Part D claims for 40 patients. 94% of them were for generic drugs. CMS names the drug for 71 of them, across 2 drugs with 11 or more claims each, at $1,343 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Mirza for performance year 2024, reported as part of a group. Dr. Mirza accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 27 papers to Dr. Mirza, published from 2015 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Black or African American, Florida and Leukemia, Myeloid, Acute. Dr. Mirza has published most often in Blood. Dr. Mirza's most frequent co-authors are Taiga Nishihori, MD, Lohith Gowda, MD and Hamza Hashmi, MD.

CMS Open Payments shows 81 general payments to Dr. Mirza from 10 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Bristol-Myers Squibb Company paid the most, $57,577.

Dr. Mirza graduated from University of South Florida Morsani College of Medicine in 2016.

Dr. Mirza is in network with 8 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.